All patients
age >= 60 yr autoimmune disease invasive ventilation no oxygen needed non invasive oxygen
corticosteroids in COVID 19 hospitalized - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias death D28detailed results Metcovid, 2020 0.92 [0.67; 1.28]
Tang X, 2020 0.98 [0.93; 1.02]
0.98 [0.93 ; 1.02 ] Metcovid, 2020, Tang X, 2020 2 0% 479 moderate not evaluable deathsdetailed results CAPE-COVID, 2020 0.45 [0.20; 1.02]
Metcovid, 2020 0.92 [0.67; 1.28]
Tang X, 2020 0.98 [0.93; 1.02]
0.91 [0.73 ; 1.14 ] CAPE-COVID, 2020, Metcovid, 2020, Tang X, 2020 3 44% 628 moderate not evaluable clinical deteriorationdetailed results Tang X, 2020 1.00 [0.13; 7.45]
1.00 [0.13 ; 7.45 ] Tang X, 2020 1 0% 86 NA not evaluable clinical improvementdetailed results Tang X, 2020 1.04 [0.67; 1.62]
1.04 [0.67 ; 1.62 ] Tang X, 2020 1 0% 86 NA not evaluable clinical improvement (14-day)detailed results Tang X, 2020 1.33 [0.57; 3.11]
1.33 [0.57 ; 3.11 ] Tang X, 2020 1 0% 86 NA not evaluable clinical improvement (time to event analysis only)detailed results Tang X, 2020 1.04 [0.67; 1.62]
1.04 [0.67 ; 1.62 ] Tang X, 2020 1 0% 86 NA not evaluable death or ventilationdetailed results CAPE-COVID, 2020 0.71 [0.37; 1.35]
0.71 [0.37 ; 1.35 ] CAPE-COVID, 2020 1 0% 149 NA not evaluable hospital dischargedetailed results CAPE-COVID, 2020 1.67 [0.87; 3.19]
1.67 [0.87 ; 3.19 ] CAPE-COVID, 2020 1 0% 149 NA not evaluable mechanical ventilationdetailed results CAPE-COVID, 2020 0.95 [0.44; 2.04]
Metcovid, 2020 1.19 [0.56; 2.49]
1.06 [0.62 ; 1.81 ] CAPE-COVID, 2020, Metcovid, 2020 2 0% 337 moderate not evaluable viral clearance detailed results Tang X, 2020 1.78 [1.06; 3.00]
1.78 [1.06 ; 3.00 ] Tang X, 2020 1 0% 86 NA not evaluable viral clearance (time to event analysis only)detailed results Tang X, 2020 1.78 [1.06; 3.00]
1.78 [1.06 ; 3.00 ] Tang X, 2020 1 0% 86 NA not evaluable ICU admissiondetailed results Tang X, 2020 1.00 [0.13; 7.45]
1.00 [0.13 ; 7.45 ] Tang X, 2020 1 0% 86 NA not evaluable superinfectiondetailed results CAPE-COVID, 2020 0.81 [0.49; 1.34]
Metcovid, 2020 0.98 [0.65; 1.47]
0.91 [0.66 ; 1.25 ] CAPE-COVID, 2020, Metcovid, 2020 2 0% 542 moderate not evaluable 0.5 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-05-16 19:04 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
studied treatment is better when TE > 1;
studied treatment is better when TE < 1;
pathologies: 95,94,90,91
- treatments: 522,582,666,1149,1150,737,544,733
- roots T: 290